Salmeterol belongs to a class of drugs called bronchodilators. A bronchodilator is a medication that helps relax the muscles around the airways, which helps air move in and out of the lungs.

Weinberger and Abu-Hasan (Aug. 24 issue) 1 report severe asthma in two patients receiving inhaled corticosteroids and salmeterol. Each actuation of the salmeterol inhaler also delivers xinafoate ...

Generic fluticasone-salmeterol demonstrated similar safety and effectiveness as the brand-name version among patients with chronic obstructive pulmonary disease, according to researchers.The FDA ...

Patients with chronic asthma who use the salmeterol on a daily basis are at increased risk for serious adverse events, researchers conclude in the latest issue of The Cochrane Library.

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26[Erratum, Chest 2006;129:1393 ...

Compared with placebo, salmeterol was associated with a reduced number of patients having COPD exacerbations (20.3% vs. 27.8%, NNT 14), based on four good-quality parallel trials with 1,741 patients.

Aug. 19, 2003 — New safety information and warnings have been added to the labeling for drug products that contain salmeterol, a long-acting bronchodilator used to treat asthma and chronic ...

DALLAS – Once-daily umeclidinium improved all lung function measures compared with twice-daily salmeterol in patients with chronic obstructive pulmonary disease (COPD) who were naive to ...

Is the addition of inhaled salmeterol to inhaled corticosteroids a better treatment option for some asthma patients than the addition of oral zafirlukast?

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789. 4. Rabe KF. Treating COPD: the TORCH trial, P values, and the dodo ...

Salmeterol is a long-acting β2-agonist that activates adenylate cyclase, causing long-lasting bronchodilation and has been used for many years to control asthma. However, little information is ...

Reason for posting: A large, placebo-controlled trial of Serevent (salmeterol), a long-acting β2-receptor agonist (LABA), was recently stopped early amid concerns that the drug may be associated with ...